glp-1 agonist dpp 4 inhibitor Clinical Use of DPP-4 Inhibitors Insight into Structure Activity Relationship
Description
doi: 10.1093/carcin/bgp280
Relationship of glicentin to proglucagon and glucagon in the porcine pancreas
In secondary analyses within the GLP-1RA group, continued use was compared with the other scenarios
The goal remains optimizing diabetes management or weight loss while maintaining acceptable tolerability and patient well-being
Found Health describes these as sometimes prescribed in combination with GLP-1 medications for a more personalized approach
